Evidence map›Paper›PMID 25497456›Full record

ArticleStem cell reports2015

C-MYC transcriptionally amplifies SOX2 target genes to regulate self-renewal in multipotent otic progenitor cells.

Kelvin Y Kwan, Jun Shen, David P Corey

Open access · goldAbstract read
In one paragraph

Article in Stem cell reports, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 54 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
54citing papers in PubMed, 1 pooled it
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

54 citing papers in PubMed, 1 synthesis or guideline pooled it, 71 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Expandable Lung Epithelium Differentiated from Human Embryonic Stem Cells.Tissue engineering and regenerative medicine · 2022
    Article
  11. False-positive IRESes fromProceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Molecular Aspects of the Development and Function of Auditory Neurons.International journal of molecular sciences · 2020
    Review
  19. Article
  20. Targeting SOX2 Protein with Peptide Aptamers for Therapeutic Gains against Esophageal Squamous Cell Carcinoma.Molecular therapy : the journal of the American Society of Gene Therapy · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 1 country.

Kelvin Y KwanDepartment of Cell Biology & Neuroscience, Rutgers University, Piscataway, NJ 08854, USA. Electronic address: kwan@dls.rutgers.edu.
Jun ShenHoward Hughes Medical Institute, Department of Neurobiology, Harvard Medical School Boston, MA 02115, USA; Department of Pathology, Brigham and Women's Hospital, Boston, MA 02115, USA.
David P CoreyHoward Hughes Medical Institute, Department of Neurobiology, Harvard Medical School Boston, MA 02115, USA.
Brigham and Women's Hospital · USHoward Hughes Medical Institute · USRutgers, The State University of New Jersey · US

Funding

SYNAPTIC MECHANISMS IN HIPPOCAMPAL EPILEPTOGENESISP30HD018655 · NICHD · CHILDREN'S HOSPITAL BOSTON · PI POMEROY, SCOTT LOREN · 1985 to 2015
$26.2M
MOLECULAR MECHANISMS OF AUDITORY TRANSDUCTIONR01DC000304 · NIDCD · MASSACHUSETTS GENERAL HOSPITAL · PI DAVID P COREY, Marcos Sotomayor · 1989 to 2026
$9.3M
MOLECULAR BASIS OF INHERITED DEAFNESSR01DC002281 · NIDCD · MASSACHUSETTS GENERAL HOSPITAL · PI COREY, DAVID P · 1994 to 2018
$4.4M
Clinical Molecular Genetic Diagnosis of Hearing LossR03DC013866 · NIDCD · BRIGHAM AND WOMEN'S HOSPITAL · PI SHEN, JUN · 2014 to 2016
$601k
Howard Hughes Medical InstituteNICHD NIH HHS P30 HD018655NIDCD NIH HHS R01 DC000304NIDCD NIH HHS R01DC000304NIDCD NIH HHS R01 DC002281NIDCD NIH HHS R01DC002281NIDCD NIH HHS R03 DC013866
6 · The paper itself

Abstract

Sensorineural hearing loss is caused by the loss of sensory hair cells and neurons of the inner ear. Once lost, these cell types are not replaced. Two genes expressed in the developing inner ear are c-Myc and Sox2. We created immortalized multipotent otic progenitor (iMOP) cells, a fate-restricted cell type, by transient expression of C-MYC in SOX2-expressing otic progenitor cells. This activated the endogenous C-MYC and amplified existing SOX2-dependent transcripts to promote self-renewal. RNA-seq and ChIP-seq analyses revealed that C-MYC and SOX2 occupy over 85% of the same promoters. C-MYC and SOX2 target genes include cyclin-dependent kinases that regulate cell-cycle progression. iMOP cells continually divide but retain the ability to differentiate into functional hair cells and neurons. We propose that SOX2 and C-MYC regulate cell-cycle progression of these cells and that downregulation of C-MYC expression after growth factor withdrawal serves as a molecular switch for differentiation.

Indexed as

Gene AmplificationGene Expression RegulationAnimalsBiomarkersCell DifferentiationCell LineCell ProliferationCellular MicroenvironmentFibroblast Growth Factor 2Gene ExpressionGene Expression ProfilingHair Cells, AuditoryInduced Pluripotent Stem CellsKaryotypeMiceMultipotent Stem CellsBiomarkersFibroblast Growth Factor 2Proto-Oncogene Proteins c-mycSOXB1 Transcription Factors

Identifiers

PMID25497456
PMCPMC4297878
OpenAlexW2090185129

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.